It is with great pleasure to announce and to invite you to join us at The 2nd Asia Pacific Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy - DIPAP Greater China to take place this coming October 26-28, 2017 in Shanghai, China.
The Symposium is held in order to highlight and document scientifically and practically on how to prevent, diagnose and manage HIP to optimize care and outcomes in what is seen as a large knowledge gap within the field.
The Non Communicable Disease & Pregnancy global epidemic - It’s all about the mother and the offspring
The Non Communicable Disease & Pregnancy – The FIGO Global vision
The IDF Global Vision: Diabetes in Pregnancy
Maternal Health – The Impact of Diabetes, Obesity, Hypertension in Pregnancy
The Mother with Pregnancy Induced Complications – How do we Improve Outcome?
The Fetus - Is There an Optimal Birth Weight?
The Fetus - Prevention of Preterm Birth: Towards Healthy Mothers and Healthy Babies
Renovating Maternal Fetal Medicine
Maternal Fetal Medicine - The Great Obstetrical Syndromes; from basics to molecular biology
Fetal Medicine - Innovations in prediction and prevention
New technologies in diabetic pregnancy
Placental insufficiency: preeclampsia and fetal growth
The pathogenesis of preeclampsia: Clues to prevention and treatment
Preeclampsia: identification of pre-clinical disease and management issues
Early prediction and prevention of IUGR
IUGR and SGA: Doppler management and prediction of outcomeObesity or Metabolic Syndrome in Pregnancy, which is more hazardous to the mother and offspring?
Perinatal programming of obesity
Pre-pregnancy management of the obese patient
Health system and societal barriers in improving diabetes related maternal health
Towards a Consensus; The FIGO-GDM Initiative Project
The Asia Pacific Experience: Learning from the SAIDIP & Greater China experience
Tribulations and triumphs in implementing a national strategy for GDM screening diagnosis and care in India
Analysis of the cost-effectiveness of carrying out GDM screening in India
Gestational diabetes mellitus in China: Difficulties and coping strategies
Analysis of the cost-effectiveness of carrying out GDM screening in China
State of the art on insulin analogues and pregnancy
Differences between early and late onset placental disease - implications for screening
Aspects of preeclampsia risk calculation: Populations and individuals
First-trimester maternal risk assessment - A health economic perspective
Critical evaluation of potential treatments: The case for/against aspirin
Towards a solution - The ASPRE Study
Nutritional factors and supplementation on maternal and infant outcome
Diet and pregnancy outcomes- examples based on the role of micronutrients and macronurients in the development of gestational diabetes
Nutritional supplementation and the prevention of fetal congenital abnormalitie
Differences in growth trajectories between infants of women with type-1 and type-2 diabetes?
Abstract Submission Deadline